冠動脈脈逆輸血による心臓発作の縮小
1Department of Cardiothoracic Surgery, Boston University Medical Center, MA.
Circulation
|November 1, 1992
まとめ
圧力制御断続性冠動脈閉症 (PICSO) とL-グルタミン酸は,緊急の再血管化手術中の心臓損傷を軽減します. このテクニックは,心臓の機能を改善し,急性冠動脈閉塞後の組織損傷を最小限に抑えます.
科学分野:
- 心血管外科手術についてです.
- 発血性心臓病 発血性心臓病 発血性心臓病 発血性心臓病とは
- 心筋臓の保護について
背景:
- 手術による再血管化を施した時の急性冠動脈閉塞は,有意な不血性損傷につながる可能性があります.
- これらの重要な状況で組織損傷を最小限に抑えるために,心筋膜の保護戦略は極めて重要です.
研究 の 目的:
- 圧力を制御した断続性冠動脈シヌス閉塞 (PICSO) を使用して冠動脈静脈逆輸の有効性を評価する.
- PICSOとL-グルタマート基板強化剤の併用による,不全性損傷の軽減に対する効果を評価する.
主な方法:
- 手術による冠動脈閉塞の豚モデルを使用した.
- グループには,PICSOのみ,PICSO 含有酸素の血液,PICSO 含有 L-グルタミン酸,または介入なし (未修正) を投与した.
- 測定には,壁の運動スコア,死滅とリスク領域の比率,および組織酸化 (pH) が含まれていました.
主要な成果:
- PICSO単独およびL-グルタミン酸と併用すると,修正されていないグループと比較して,壁の運動スコアを大幅に改善しました.
- 両 PICSO グループは,ネクロス領域とリスク領域の比率が著しく低いことを示しました.
- PICSOとL-グルタミン酸で治療された心臓では,組織酸化が有意に減少しました.
結論:
- PICSOによる冠動脈脈逆輸注は,不血性損傷の軽減に効果的です.
- PICSOとL-グルタミン酸を併用すると,手術による再血管化を施す際に心筋膜の保護がさらに強化されます.
- これらの発見は,PICSOを心筋臓の保存のための貴重な補助物として支持しています.
関連する概念動画
Anatomy of the Heart
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


